Salles B, Charcosset J Y, Jacquemin-Sablon A
Cancer Treat Rep. 1982 Feb;66(2):327-38.
Chinese hamster lung cells resistant to 9-OH-ellipticine (9-OH-E) were selected in vitro by adding stepwise increasing drug concentrations to the cell growth medium. This selection procedure resulted in the isolation of two sublines, about tenfold and 12-fold resistant to 9-OH-E. This level of resistance did not increase even after about 30 months of drug exposure. Cytogenetic studies revealed that the resistant cells carry several discrete karyotype modifications, the most striking being the absence of one No. 5 chromosome and the presence of a marker chromosome characterized by peculiar G-banding. Development of 9-OH-E resistance was also associated with some changes in cell properties such as modifications of morphology and growth parameters, lower oncogenic potential, and cross-resistance to a variety of antitumor agents. Although these results suggest that the resistance is associated with a modification of cell membrane properties, drug uptake studies did not show any significant difference between the parental sensitive cells and the resistant sublines.
通过在细胞生长培养基中逐步增加药物浓度,在体外筛选出对9-羟基玫瑰树碱(9-OH-E)具有抗性的中国仓鼠肺细胞。这种筛选过程导致分离出两个亚系,它们对9-OH-E的抗性分别约为10倍和12倍。即使在药物暴露约30个月后,这种抗性水平也没有增加。细胞遗传学研究表明,抗性细胞带有几种离散的核型改变,最显著的是缺少一条5号染色体和存在一条由特殊G带特征的标记染色体。9-OH-E抗性的产生还与细胞特性的一些变化有关,如形态和生长参数的改变、较低的致癌潜力以及对多种抗肿瘤药物的交叉抗性。尽管这些结果表明抗性与细胞膜特性的改变有关,但药物摄取研究并未显示亲代敏感细胞和抗性亚系之间有任何显著差异。